[
  {
    "ts": "2025-12-22T10:04:00+00:00",
    "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
    "summary": "Investors can expect steady dividend returns with these stocks.",
    "url": "https://www.fool.com/investing/2025/12/22/want-decades-of-passive-income-3-stocks-to-buy-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "ebe6264a-1519-39c8-8af5-290095b9a27b",
      "content": {
        "id": "ebe6264a-1519-39c8-8af5-290095b9a27b",
        "contentType": "STORY",
        "title": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
        "description": "",
        "summary": "Investors can expect steady dividend returns with these stocks.",
        "pubDate": "2025-12-22T10:04:00Z",
        "displayTime": "2025-12-22T10:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/11ab9b52965ed6d9b92fb0ac0dda1149",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A tablet showing a word cloud prominently featuring \"passive income.\"",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LK7wX1FrJCZHTnfGgf5xyg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/11ab9b52965ed6d9b92fb0ac0dda1149.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rWLeHYd4IRU5jpv8L14hSg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/11ab9b52965ed6d9b92fb0ac0dda1149.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/22/want-decades-of-passive-income-3-stocks-to-buy-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/want-decades-passive-income-3-100400631.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "O"
            },
            {
              "symbol": "KO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-22T18:43:00+00:00",
    "headline": "Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends",
    "summary": "XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership.",
    "url": "https://finance.yahoo.com/news/bet-top-ranked-healthcare-etfs-184300571.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2dc54035-691e-35fa-af3d-c59a4fb8694a",
      "content": {
        "id": "2dc54035-691e-35fa-af3d-c59a4fb8694a",
        "contentType": "STORY",
        "title": "Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends",
        "description": "",
        "summary": "XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership.",
        "pubDate": "2025-12-22T18:43:00Z",
        "displayTime": "2025-12-22T18:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3GkkLZFYbl52wnpptRqd1w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7SzRmhAvDPGiiSvT8MWFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bet-top-ranked-healthcare-etfs-184300571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bet-top-ranked-healthcare-etfs-184300571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "IHE"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-22T23:10:20+00:00",
    "headline": "What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders",
    "summary": "Earlier in December 2025, OSE Immunotherapeutics amended its partnership with AbbVie over the inflammatory disease candidate ABBV-230, with OSE taking back control of preclinical and Phase 1 work, at its own funding risk, while AbbVie kept exclusive rights to later-stage development and commercialization on unchanged economic terms. The revised ABBV-230 arrangement underlines AbbVie’s willingness to lean on partners’ early-stage immunology expertise while reserving control of potential...",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-restructured-ose-immunology-231020444.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "706075f5-de1a-3df5-bab8-3d2de8a2b2a5",
      "content": {
        "id": "706075f5-de1a-3df5-bab8-3d2de8a2b2a5",
        "contentType": "STORY",
        "title": "What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders",
        "description": "",
        "summary": "Earlier in December 2025, OSE Immunotherapeutics amended its partnership with AbbVie over the inflammatory disease candidate ABBV-230, with OSE taking back control of preclinical and Phase 1 work, at its own funding risk, while AbbVie kept exclusive rights to later-stage development and commercialization on unchanged economic terms. The revised ABBV-230 arrangement underlines AbbVie’s willingness to lean on partners’ early-stage immunology expertise while reserving control of potential...",
        "pubDate": "2025-12-22T23:10:20Z",
        "displayTime": "2025-12-22T23:10:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cbaG7tZ9A8mqrilci3AeIQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1OA9tdPdimVe1Dv1fa4MAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4451284b0632c6e74466a63400764edd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-restructured-ose-immunology-231020444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-restructured-ose-immunology-231020444.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "OSE.PA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]